Rank–rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Comparing independent high-throughput gene-expression experiments can generate hypotheses about which gene-expression programs are shared between particular biological processes. Current techniques to compare expression profiles typically involve choosing a fixed differential expression threshold to summarize results, potentially reducing sensitivity to small but concordant changes. We present a threshold-free algorithm called Rank-rank Hypergeometric Overlap (RRHO). This algorithm steps through two gene lists ranked by the degree of differential expression observed in two profiling experiments, successively measuring the statistical significance of the number of overlapping genes. The output is a graphical map that shows the strength, pattern and bounds of correlation between two expression profiles. To demonstrate RRHO sensitivity and dynamic range, we identified shared expression networks in cancer microarray profiles driving tumor progression, stem cell properties and response to targeted kinase inhibition. We demonstrate how RRHO can be used to determine which model system or drug treatment best reflects a particular biological or disease response. The threshold-free and graphical aspects of RRHO complement other rank-based approaches such as Gene Set Enrichment Analysis (GSEA), for which RRHO is a 2D analog. Rank-rank overlap analysis is a sensitive, robust and web-accessible method for detecting and visualizing overlap trends between two complete, continuous gene-expression profiles. A web-based implementation of RRHO can be accessed at http://systems.crump.ucla.edu/rankrank/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. RRHO identifies statistically significant overlap between expression signatures supporting or generating biological hypotheses. (A) High overlap in gene-expression changes between mouse models of prostate neoplasia driven by PTEN and AKT, both in the PI3K signaling pathway, identifying genes consistently modulated by two different perturbations in the same pathway during tumorigenesis [hypergeometric P-value (HP) 10−27] (22,26). (B) Increasing overlap of castration signature with PTEN-knockout-driven prostate cancer over time (minimum HP 10−27) (22,27). Each map shows the overlap between non-cancerous prostate tissue following castration in a mouse (compared to prostate tissue from uncastrated mice) and a mouse model of prostate cancer driven by PTEN loss (compared to prostate tissue from wild-type littermates). The degree of overlap increases with time and is reversed when testosterone is given for 3 days. (C) Significant overlap between a stem cell signature from murine mammary glands and BCR-ABL fusion onco-protein signature (HP 10−8) (30,31). (D) High overlap between gene-expression changes driven by overexpression of KRAS2 oncogene in a cell line and by mutated KRAS2 in human lung tumors, identifying signaling events downstream of this oncogene that are potentially clinically relevant and can be studied in the cell line model (HP 10−24) (35). (E) High overlap between treatment with the small-molecule inhibitor imatinib in two leukemia patient populations, identifying higher confidence markers for drug response (HP 10−141) (21,36). (F) Significant overlap between cell line-derived profiles from different tissue types based on sensitivity to the small-molecule inhibitor dasatinib, identifying possible adaptation mechanisms which can be targeted for higher drug efficacy (HP 10−33) (38,39). The tick mark on each axis indicates the point in the ranked gene-expression signature list where the direction of differential expression switches. A permutation P-value based on the sum of the signal in bottom left and top right regions (perm pval) or when permutations are not possible the maximum of the BY-corrected RRHO map (max BY) is indicated.](https://figures.cochat.ai/paper-figures/4c4ab8f0325f4c889aaa285e0f546c61/rankrank-hypergeometric-overlap-identification-of-statistically-significant-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, while these approaches are useful, they have conceptual limitations. Some lack a clear estimand (such as the running-sum GSEA statistic); some have ambiguous units (such as the energy distance); some are biased at finite sample size (such as the proportion of DE genes π in iDEA, see O’Connor et al11).”
From Transcriptome-wide analysis of differential expression in perturbation atlases (2025) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“Consistently, rank-rank hypergeometric transcriptional overlap (RRHO) mapping between pre-natal and adult brain, and between iPSC-iNs and iNs, revealed a pronounced bias in the overlap of iNs with adult brain samples (Figure 7M; Plaisier et al., 2010).”
From Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer’s patients (2021) · cites this paper as Plaisier et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 3×
“In the SAM/GSEA approach, the output is a permutation P-value and a Kolmogorov–Smirnov mountain plot illustrating the overlap between a subset of high-ranking genes chosen to represent the mouse model profile (a fixed gene set) and the range of differential gene expression in the human data set (a continuous ranked li…”
MethodGene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · cited 2×
“Gene-expression information from microarray data repositories such as Gene-expression Omnibus (19) and ArrayExpress (53) as well as from more specialized resources such as the drug response profile database Cmap (10) can be readily converted to ranked list inputs for our program.”
BackgroundMethodThe control of the false discovery rate in multiple testing under dependency
Benjamini, Y., & Yekutieli, D. (2001) · The Annals of Statistics · doi:10.1214/aos/1013699998 · Cited by 10,490
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257 · cited 20×
“is the Cmap, a database of transcriptional responses to a panel of specific drug treatments (10).”
BackgroundMethodInfluentialGenes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 1×
“The x-axis on all representations shows the difference between ER positive to ER negative human breast tumors (24); the y-axis shows gene-expression profiles based on other mutations or other profiles relevant to human breast cancer.”
BackgroundOncogenic pathway signatures in human cancers as a guide to targeted therapies
Bild, A. H., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., Joshi, M.-B., Harpole, D., Lancaster, J. M., Berchuck, A., et al. (2006) · Nature · doi:10.1038/nature04296 · Cited by 2,032 · cited 2×
“High overlap between gene-expression changes driven by mutated KRAS2 oncogene in human lung tumors and by overexpression of KRAS2 in a cell line identify signaling events downstream of this oncogene that have in vivo relevance that can be studied effectively in vitro (Figure 3D) (35).”
BackgroundUsing GOstats to test gene lists for GO term association
Falcon, S., & Gentleman, R. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btl567 · Cited by 2,015
Empirical Bayes analysis of a microarray experiment
Efron, B., Tibshirani, R., Storey, J. D., & Tusher, V. (2001) · Journal of the American Statistical Association · doi:10.1198/016214501753382129 · Cited by 1,733 · cited 7×
“Comparing the permutation P-values from the SAM/GSEA approach to those from the RRHO approach demonstrates that both methods have equivalent sensitivity and are able to detect the weak but statistically significant cross-species signal (Figure 4D).”
MethodInfluentialPurification and unique properties of mammary epithelial stem cells
Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H. I., & Eaves, C. J. (2006) · Nature · doi:10.1038/nature04496 · Cited by 1,559 · cited 2×
“We identified another example of overlap between the stem cell phenotype and a signaling signature by comparing the gene-expression profile of mammary stem cells that can regenerate a murine mammary gland (versus myoepithelial cells that do not have this regenerative potential) to the gene-expression profile activated…”
BackgroundGene-Expression Signatures in Breast Cancer
Sotiriou, C., & Pusztai, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801289 · Cited by 1,485
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109 · cited 5×
“(B) Increasing overlap of castration signature with PTEN-knockout-driven prostate cancer over time (minimum HP 10 (27)) (22,27).”
BackgroundMethodInfluentialMultiple Hypothesis Testing in Microarray Experiments
Dudoit, S., Shaffer, J. P., & Boldrick, J. C. (2003) · Statistical Science · doi:10.1214/ss/1056397487 · Cited by 1,075 · cited 2×
“BY proved that a conservative modification of the BY FDR correction would accommodate arbitrary dependencies in testing (18).”
MethodArrayExpress--a public repository for microarray gene expression data at the EBI
Parkinson, H. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki056 · Cited by 1,075 · cited 1×
“Data downloaded from Array Express (20): imatinib treatment in leukemia patients, E-MEXP-433 (21).”
MethodRhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., & Chinnaiyan, A. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401994101 · Cited by 1,019
On testing the significance of sets of genes
Efron, B., & Tibshirani, R. (2007) · The Annals of Applied Statistics · doi:10.1214/07-aoas101 · Cited by 798
ArrayExpress--a public repository for microarray gene expression data at the EBI
Brazma, A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg091 · Cited by 774
ArrayExpress--a public database of microarray experiments and gene expression profiles
Parkinson, H., Kapushesky, M., Shojatalab, M., Abeygunawardena, N., Coulson, R., Farne, A., Holloway, E., Kolesnykov, N., Lilja, P., Lukk, M., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl995 · Cited by 752 · cited 1×
“Gene-expression information from microarray data repositories such as Gene-expression Omnibus (19) and ArrayExpress (53) as well as from more specialized resources such as the drug response profile database Cmap (10) can be readily converted to ranked list inputs for our program.”
BackgroundSTRING 7--recent developments in the integration and prediction of protein interactions
von Mering, C., Jensen, L. J., Kuhn, M., Chaffron, S., Doerks, T., Kruger, B., Snel, B., & Bork, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl825 · Cited by 665
Basso, A. D., Solit, D. B., Chiosis, G., Giri, B., Tsichlis, P., & Rosen, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206322200 · Cited by 628
Hieronymus, H., Lamb, J., Ross, K. N., Peng, X. P., Clement, C., Rodina, A., Nieto, M., Du, J., Stegmaier, K., Raj, S. M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.005 · Cited by 624 · cited 3×
“Similarly, mean Cmap scores were calculated for each drug using the top 50 genes that increased and decreased by gedunin treatment relative to controls—the exact same gedunin signature-based gene sets used in the original Cmap analysis (43).”
BackgroundMethodc-Src and cooperating partners in human cancer
Ishizawar, R., & Parsons, S. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.001 · Cited by 617 · cited 1×
“Elevated SRC kinase activity has been implicated in contributing to many tumor types (37).”
BackgroundSubclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Hoshida, Y., Brunet, J.-P., Tamayo, P., Golub, T. R., & Mesirov, J. P. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001195 · Cited by 614 · cited 1×
“Alternatively, approaches such as subclass mapping allow the comparison of clusters of genes that have similar expression patterns within subsets of samples in different profiling experiments (5).”
MethodLee, J.-S., Chu, I.-S., Mikaelyan, A., Calvisi, D. F., Heo, J., Reddy, J. K., & Thorgeirsson, S. S. (2004) · Nature Genetics · doi:10.1038/ng1481 · Cited by 475
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T. (2005) · Nature Genetics · doi:10.1038/ng1490 · Cited by 414 · cited 6×
“Data downloaded from an individual lab website: KRAS2 lung tumors and mouse model (1), Cmap database (10).”
BackgroundMethodInfluentialJiang, X., Zhao, Y., Smith, C., Gasparetto, M., Turhan, A., Eaves, A., & Eaves, C. (2007) · Leukemia · doi:10.1038/sj.leu.2404609 · Cited by 359
Huang, F., Reeves, K., Han, X., Fairchild, C., Platero, S., Wong, T. W., Lee, F., Shaw, P., & Clark, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3633 · Cited by 344 · cited 2×
“(F) Significant overlap between cell line-derived profiles from different tissue types based on sensitivity to the small-molecule inhibitor dasatinib, identifying possible adaptation mechanisms which can be targeted for higher drug efficacy (HP 10 (33)) (38,39).”
BackgroundSolit, D. B., Basso, A. D., Olshen, A. B., Scher, H. I., & Rosen, N. X. (2003) · PubMed · Cited by 307
Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
Chen, Y., Hu, Y., Zhang, H., Peng, C., & Li, S. (2009) · Nature Genetics · doi:10.1038/ng.389 · Cited by 293 · cited 2×
“We identified another example of overlap between the stem cell phenotype and a signaling signature by comparing the gene-expression profile of mammary stem cells that can regenerate a murine mammary gland (versus myoepithelial cells that do not have this regenerative potential) to the gene-expression profile activated…”
BackgroundProstate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model
Majumder, P. K., Yeh, J. J., George, D. J., Febbo, P. G., Kum, J., Xue, Q., Bikoff, R., Ma, H., Kantoff, P. W., Golub, T. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232229100 · Cited by 285 · cited 2×
“Both of these genetic changes lead to activation of the PI3K pathway and RRHO analysis identifies genes that are consistently modulated by these two different perturbations of the same pathway during tumorigenesis (22,26).”
BackgroundErmineJ: Tool for functional analysis of gene expression data sets
Lee, H. K., Braynen, W., Keshav, K., & Pavlidis, P. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-269 · Cited by 278
Hsp70 release from peripheral blood mononuclear cells
Hunter-Lavin, C., Davies, E. L., Bacelar, M. M. F. V. G., Marshall, M. J., Andrew, S. M., & Williams, J. H. H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.075 · Cited by 241 · cited 1×
“Monensin overlap is biologically intriguing as this drug has recently been shown to cause apoptosis synergistically with the HSP90 inhibitor 17-AAG in hepatic cells (47) and affects the release of heat shock proteins from blood cells (48).”
BackgroundInvolvement of Hsp90 in Signaling and Stability of 3-Phosphoinositide-dependent Kinase-1
Fujita, N., Sato, S., Ishida, A., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106736200 · Cited by 198
Lei, Q., Jiao, J., Xin, L., Chang, C.-J., Wang, S., Gao, J., Gleave, M. E., Witte, O. N., Liu, X., & Wu, H. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.031 · Cited by 198 · cited 1×
“This result confirms the notion that PTEN controlled signaling pathway intrinsically regulates androgen response (28,29) and PTEN loss may contribute to castration resistant prostate cancer development.”
ResultJiao, J., Wang, S., Qiao, R., Vivanco, I., Watson, P. A., Sawyers, C. L., & Wu, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4202 · Cited by 172 · cited 1×
“This result confirms the notion that PTEN controlled signaling pathway intrinsically regulates androgen response (28,29) and PTEN loss may contribute to castration resistant prostate cancer development.”
ResultMolecular Concepts Analysis Links Tumors, Pathways, Mechanisms, and Drugs
Rhodes, D. R., Kalyana-Sundaram, S., Tomlins, S. A., Mahavisno, V., Kasper, N., Varambally, R., Barrette, T. R., Ghosh, D., Varambally, S., & Chinnaiyan, A. M. (2007) · Neoplasia · doi:10.1593/neo.07292 · Cited by 142
PARDAL, R., MOLOFSKY, A. V., HE, S., & MORRISON, S. J. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.057 · Cited by 131
Fury, W., Batliwalla, F., Gregersen, P. K., & Li, W. (2006) · 2006 International Conference of the IEEE Engineering in Medicine and Biology Society · doi:10.1109/iembs.2006.260828 · Cited by 114 · cited 1×
“In both the gene set and gene cluster approaches, the size of the gene list and the number of overlapping genes calculated is dependent on the thresholds of differential expression used to create the representative gene sets (6).”
MethodGene expression signature of primary imatinib-resistant chronic myeloid leukemia patients
Frank, O., Brors, B., Fabarius, A. C., Li, L., Haak, M., Merk, S., Schwindel, U., Zheng, C., Müller, M. C., Gretz, N., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404270 · Cited by 110
Wang, X.-D., Reeves, K., Luo, F. R., Xu, L.-A., Lee, F., Clark, E., & Huang, F. (2007) · Genome Biology · doi:10.1186/gb-2007-8-11-r255 · Cited by 83 · cited 2×
“(F) Significant overlap between cell line-derived profiles from different tissue types based on sensitivity to the small-molecule inhibitor dasatinib, identifying possible adaptation mechanisms which can be targeted for higher drug efficacy (HP 10 (33)) (38,39).”
BackgroundCrossman, L. C., Mori, M., Hsieh, Y. C., Lange, T., Paschka, P., Harrington, C. A., Krohn, K., Niederwieser, D. W., Hehlmann, R., Hochhaus, A., et al. (2005) · PubMed · Cited by 68
Wang, X.-D., Wang, B.-E., Soriano, R. H., Zha, J., Zhang, Z., Modrusan, Z. D., Cunha, G. R., & Gao, W. (2006) · Differentiation · doi:10.1111/j.1432-0436.2006.00135.x · Cited by 67
Landis, M. D., Seachrist, D. D., Montanez-Wiscovich, M. E., Danielpour, D., & Keri, R. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208712 · Cited by 58 · cited 1×
“In the case of a weak signal, ER loss versus mouse model for HER2/ Neu-driven mammary tumors (25), enrichment cannot be easily visualized by plotting the distribution of P-values or ranks, thus making it necessary to use an overlap statistic-based representation such as the hypergeometric map.”
MethodPathCase: pathways database system
Elliott, B., Kıraç, M., Cakmak, A., Yavaş, G., Mayes, S., Cheng, E., Wang, Y., Gupta, C., Özsoyoğlu, G., & Ozsoyoglu, Z. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn459 · Cited by 55
Myung, S. J., Yoon, J., Kim, B. H., Lee, J., Jung, E. U., & Lee, H.-S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151860 · Cited by 52 · cited 1×
“Monensin overlap is biologically intriguing as this drug has recently been shown to cause apoptosis synergistically with the HSP90 inhibitor 17-AAG in hepatic cells (47) and affects the release of heat shock proteins from blood cells (48).”
BackgroundAn accurate computation of the hypergeometric distribution function
Wu, T. (1993) · ACM Transactions on Mathematical Software · doi:10.1145/151271.151274 · Cited by 47
GObar: A Gene Ontology based analysis and visualization tool for gene sets
Lee, J. S., Katari, G., & Sachidanandam, R. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-189 · Cited by 39
Michnick, S. W. (2006) · Nature Chemical Biology · doi:10.1038/nchembio1206-663 · Cited by 30
Wang, W., Peng, Y., Wang, Y., Zhao, X., & Yuan, Z. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05167.x · Cited by 27
IEEE Standard for Radix-Independent Floating-Point Arithmetic
(1987) · IEEE Standards · doi:10.1109/ieeestd.1987.81037 · Cited by 27
A statistical framework for consolidating "sibling" probe sets for Affymetrix GeneChip data
Li, H., Zhu, D., & Cook, M. E. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-188 · Cited by 23 · cited 1×
“Data-driven supervised statistic-based collapsing has been demonstrated to improve biological discovery (11), but RRHO is robust to other collapsing techniques such as choosing the probe with greatest variation across samples.”
MethodCross-species comparisons of cancer signaling
Graeber, T. G., & Sawyers, C. L. (2004) · Nature Genetics · doi:10.1038/ng0105-7 · Cited by 21
Self-citation
Cited by
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data
Morabito, S., Reese, F., Rahimzadeh, N., Miyoshi, E., & Swarup, V. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100498 · Cited by 1,027
Sex-specific transcriptional signatures in human depression
Labonté, B., Engmann, O., Purushothaman, I., Menard, C., Wang, J., Tan, C., Scarpa, J. R., Moy, G., Loh, Y.-H. E., Cahill, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4386 · Cited by 748
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease
Olah, M., Menon, V., Habib, N., Taga, M. F., Ma, Y., Yung, C. J., Cimpean, M., Khairallah, A., Coronas-Samano, G., Sankowski, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19737-2 · Cited by 722
Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
Mulholland, D. J., Tran, L. M., Li, Y., Cai, H., Morim, A., Wang, S., Plaisier, S., Garraway, I. P., Huang, J., Graeber, T. G., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.006 · Cited by 516
“Using a rank-rank analysis and a hypergeometric overlap algorithm (Plaisier et al., 2010), we also found this similarity between the global expression profiles of genes altered in Pten null CaPs (Pten null cancer, WT control) with those enriched after castration (castration, intact or day 0…”
MethodSelf-citation
Metadata
- Authors
- Plaisier, S. B., Taschereau, R., Wong, J. A., & Graeber, T. G.
- Affiliations
- California NanoSystems Institute (US)
- Corresponding author
- Graeber, Thomas G.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-21
- Volume
- 38
- Issue
- 17
- Pages
- e169-e169
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC2943622
- OpenAlex
- W2111065008
- Cited by
- 468
- References
- 55
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 66 · 2023: 57 · 2022: 40 · 2021: 57 · 2020: 51 · 2019: 34 · 2018: 27 · 2017: 17 · 2016: 12 · 2015: 9 · 2014: 6 · 2013: 4 · 2012: 4
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- U.S. Department of Health and Human Services
- Alfred P. Sloan Foundation
- National Cancer Institute (T32CA09056, T32CA009056)
- National Institute of General Medical Sciences (T32GM008652)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Keywords
- tumor progression, stem cell properties, web-based analysis tool
- MeSH terms
- Algorithms, Animals, Computer Graphics, Data Interpretation, Statistical, Humans, Neoplasms, Gene Expression Profiling, Databases, Genetic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.